Company attributes
Other attributes
Oxford Drug Design Limited is a company that focuses on developing and delivering services and technologies for computer-aided drug discovery. The company was founded by Graham Richards in 2001 in Oxford, Oxfordshire, United Kingdom.
The company has a multidisciplinary research team that has brought together breakthroughs in computational chemistry, chem-informatics, mathematics, cloud computing, and SaaS delivery methods to create a drug discovery platform. The company looks to develop new antibiotics with novel modes of action while focusing on techniques to reduce the development of bacterial resistance. The company has identified three classes of inhibitors or aaRS enzymes which have antibiotic activity against critical Gram-negative pathogens while maintaining activity against strains resistant to standard antibiotics.
Oxford Drug Design is a company that spun out from Professor Graham Richard's group at the University of Oxford in 2001. They have developed rapid virtual screening and ligand analogue searching technologies. The platform applies machine learning techniques such as neural networks and topological data analysis to further the drug discovery process.
